30-Apr-2024
Biotech Sector: M&A Fuels Renewed Excitement
TipRanks (Tue, 30-Apr 6:53 AM ET)
PRNewswire (Mon, 22-Apr 4:05 PM ET)
Biohaven Announces Pricing of $230 Million Public Offering of Common Shares
PRNewswire (Thu, 18-Apr 6:00 AM ET)
Biohaven Announces Proposed Public Offering of Common Shares
PRNewswire (Wed, 17-Apr 4:05 PM ET)
PRNewswire (Sat, 13-Apr 9:00 AM ET)
PRNewswire (Thu, 29-Feb 4:05 PM ET)
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
Biohaven Ltd. Common Shares trades on the NYSE stock market under the symbol BHVN.
As of April 30, 2024, BHVN stock price declined to $38.80 with 1,003,590 million shares trading.
BHVN has a beta of 1.89, meaning it tends to be more sensitive to market movements. BHVN has a correlation of 0.08 to the broad based SPY ETF.
BHVN has a market cap of $3.42 billion. This is considered a Mid Cap stock.
In the last 3 years, BHVN stock traded as high as $152.56 and as low as $7.10.
The top ETF exchange traded funds that BHVN belongs to (by Net Assets): VTI, VB, IWM, VBR, VXF.
BHVN has outperformed the market in the last year with a return of +196.6%, while the SPY ETF gained +22.3%. However, in the most recent history, BHVN shares have underperformed the stock market with its stock returning -11.4% in the last 3 month period and -11.4% for the last 2 week period, while SPY has returned +2.6% and -0.3%, respectively.
BHVN support price is $38.10 and resistance is $41.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BHVN stock will trade within this expected range on the day.